Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The Rotterdam Study aims to understand various diseases in older adults.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

The document concludes that the exact way alcohol causes harm to fetal development is unknown, but it significantly affects nutrient transport to the fetus and a safe level of alcohol during pregnancy is not determined.

Genetic factors can help predict male pattern baldness risk.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

DHT may increase the risk of heart disease and death in elderly men.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

Fetal skin heals without scarring due to unique cells and processes not present in adult skin healing.

Coats' Plus is a genetic disorder with eye abnormalities, brain calcification, poor growth, bone and skin issues, and movement disorders.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Hydrogels could lead to better treatments for wound healing without scars.

Minoxidil lowers blood pressure effectively but may cause unwanted hair growth and other side effects.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Some men with early hair loss may have a condition similar to PCOS in women.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Using steroids can increase the risk of heart problems.

Adrenal disorders can cause lasting brain and behavior issues in children.

The research found genetic differences in identical twins that could explain why one twin has a disease while the other does not.

Genetically-altered adult stem cells can help in wound healing and are becoming crucial in regenerative medicine and drug design.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.